anxiety and semaglutide People with pre-existing depression or were less likely to have mental health worsening while taking a GLP-1 medication, observational Swedish data suggested. https://www.medpagetoday.com/psychiatry/generalpsychiatry/120515 Study reveals weight-loss jabs may

In addition, it important to safeguard muscle, bone, and metabolic health when losing weight

One difference worth noting: short-acting drugs like exenatide maintain their stomach-slowing effects over time, while long-acting drugs like semaglutide tend to show reduced effects after about two weeks , as the body adapts to continuous receptor stimulation

In 2021, the Food and Drug Administration (FDA) approved the brand-name version of semaglutide, Wegovy, for chronic weight management in adults with obesity or overweight

American Psychiatric Association (2013) Diagnostic and statistical Manual of Mental disorders

Standard protocol: begin semaglutide at 0.25 mg weekly, titrate to 1.02.4 mg over 1220 weeks (standard dose escalation), then add sermorelin once GI symptoms stabilise and appetite suppression plateaus